| Literature DB >> 32237461 |
Si-Hong Yang1, Yue Zhang2, Xiao-Feng Lin3, Jian-Min Wen4, Xue Bai1, Sai-Nan Fang1, Ying-Jie Guan1, Wei Chen1.
Abstract
To systematically evaluate the clinical efficacy and safety of Cheezheng Pain Relieving Plaster in the treatment of soft tissue injury. Four Chinese databases(namely CNKI, WanFang, VIP, CBM) and 2 English databases(namely PubMed, Cochrane Library) were retrieved from the establishment of each database to March 2019. The randomized controlled trials of Cheezheng Pain Relieving Plaster compared with routine therapy in treatment of soft tissue injury were included. The quality of the included studies was assessed using the Cochrane Risk Assessment Tool. Five studies were included, and 367 patients were enrolled. None of the included studies reported randomized concealment, blinding, follow-up and dropping off. The results showed that Cheezheng Pain Relieving Plaster may have advantages in alleviating joint pain, swelling, tenderness and dysfunction and other symptoms, with no serious adverse reaction. Compared with routine therapy, Cheezheng Pain Relieving Plaster may have advantages in the treatment of soft tissue injury. However, due to the quality of the included RCTs, the conclusions of this study were limited. In addition, to produce high-quality evidences for the clinical application of Cheezheng Pain Relieving Plaster, the conclusions of this study shall be further verified with large-sample, scientifically designed and strictly implemented clinical trials.Entities:
Keywords: Cheezheng Pain Relieving Plaster; randomized controlled trials; soft tissue injuries; systematic review
Year: 2020 PMID: 32237461 DOI: 10.19540/j.cnki.cjcmm.20190807.501
Source DB: PubMed Journal: Zhongguo Zhong Yao Za Zhi ISSN: 1001-5302